NEW YORK and LONDON, February 17, 2016
Akari Therapeutics (NASDAQ: AKTX), an emerging growth, development-stage biopharmaceutical company, announced today that members of its management team will participate in the 2016 SunTrust Robinson Humphrey Orphan Drug Day on Tuesday, February 23, 2016 in New York, NY.